Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Langmuir ; 38(28): 8585-8594, 2022 07 19.
Artículo en Inglés | MEDLINE | ID: mdl-35793566

RESUMEN

The water body environment is related to ecological and human health. Adsorption is an effective means to remove pollutants from water bodies. Currently, the common adsorbents suffer from disadvantages such as structural instability and poor adsorption performance under acidic conditions, which not only affect the adsorption efficiency but also cause secondary pollution of water bodies. In this study, a novel aminated multiwalled carbon nanotube-doped flower-like nanocomposite was designed, where the anionic or neutral groups were protonated under acidic conditions, and it displayed a higher adsorption capacity for dyes by ion exchange, represented by methylene blue (MB) and rhodamine B (RB). WSe2 in the composite increases its adsorption sites. The adsorption efficiency of pollutants in acidic wastewater was enhanced while avoiding secondary contamination. The synthesized composites showed maximum adsorptions of 27.55 and 27.47 mg/g for MB and RB, respectively. The current work offers a novel approach to treating acidic wastewater.


Asunto(s)
Nanotubos de Carbono , Contaminantes Químicos del Agua , Adsorción , Colorantes/química , Humanos , Cinética , Fenómenos Magnéticos , Azul de Metileno/química , Nanotubos de Carbono/química , Aguas Residuales , Agua , Contaminantes Químicos del Agua/análisis
2.
Front Bioeng Biotechnol ; 10: 799744, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35795164

RESUMEN

Objectives: This research aimed to present a novel glasses-free distance random-dot stereotest system (GFDRDSS) using an eye-tracking method. Methods: A single-view autostereoscopic display applying a backlight control system combined with an eye-tracking method and the corresponding random-dot stereotest software were developed to create a GFDRDSS with a viewing distance of 5 m. The stereoacuity of 12 subjects with normal eye position was evaluated using the Randot Stereotest, Stereoscopic Test Charts vol. 3 (Yan's Charts), Distance Randot® Stereotest, and GFDRDSS. Results: The GFDRDSS could provide distinct and stable glasses-free stereoscopic perception even while the subject was moving their head. It could evaluate binocular disparities of 40-2,400 arcsec. Eleven subjects with normal near visual acuity had fine near stereovision (20-60 arcsec) using the Randot stereotest and Yan's Charts. Under refractive correction, 10 subjects had fine stereovision (≤60 arcsec) using the GFDRDSS at a distance of 5 m, and 9 had fine stereovision using the Distance Randot® Stereotest at 3 m. Other subjects described the 100 arcsec-level stereograms correctly. The results exhibited a concordance of stereoacuity within one degrade between the two distance stereotests. Conclusion: The proposed GFDRDSS can alternately project a couple of random-dot stereograms to the subjects' eyes and provide a glasses-free distance stereotest, which showed good concordance with the Distance Randot® Stereotest. More data are needed for statistical studies.

3.
Arch Biochem Biophys ; 410(2): 307-16, 2003 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-12573291

RESUMEN

Amyloid precursor protein (APP) cleaving enzyme (BACE) is the enzyme responsible for beta-site cleavage of APP, leading to the formation of the amyloid-beta peptide that is thought to be pathogenic in Alzheimer's disease (AD). Hence, BACE is an attractive pharmacological target, and numerous research groups have begun searching for potent and selective inhibitors of this enzyme as a potential mechanism for therapeutic intervention in AD. The mature enzyme is composed of a globular catalytic domain that is N-linked glycosylated in mammalian cells, a single transmembrane helix that anchors the enzyme to an intracellular membrane, and a short C-terminal domain that extends outside the phospholipid bilayer of the membrane. Here we have compared the substrate and active site-directed inhibitor binding properties of several recombinant constructs of human BACE. The constructs studied here address the importance of catalytic domain glycosylation state, inclusion of domains other than the catalytic domain, and incorporation into a membrane bilayer on the interactions of the enzyme active site with peptidic ligands. We find no significant differences in ligand binding properties among these various constructs. These data demonstrate that the nonglycosylated, soluble catalytic domain of BACE faithfully reflects the ligand binding properties of the full-length mature enzyme in its natural membrane environment. Thus, the use of the nonglycosylated, soluble catalytic domain of BACE is appropriate for studies aimed at understanding the determinants of ligand recognition by the enzyme active site.


Asunto(s)
Ácido Aspártico Endopeptidasas/química , Proteínas Recombinantes/química , Enfermedad de Alzheimer/metabolismo , Secretasas de la Proteína Precursora del Amiloide , Animales , Ácido Aspártico Endopeptidasas/metabolismo , Sitios de Unión , Células CHO , Catálisis , Dominio Catalítico , Línea Celular , Membrana Celular/metabolismo , Cromatografía Líquida de Alta Presión , Cricetinae , Relación Dosis-Respuesta a Droga , Drosophila , Endopeptidasas , Escherichia coli/metabolismo , Glicosilación , Humanos , Concentración 50 Inhibidora , Cinética , Ligandos , Luz , Membrana Dobles de Lípidos/metabolismo , Péptidos/química , Unión Proteica , Estructura Terciaria de Proteína , Proteínas Recombinantes/metabolismo , Dispersión de Radiación , Factores de Tiempo
4.
Protein Expr Purif ; 25(3): 494-502, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12182831

RESUMEN

Glycoprotein IIb-IIIa is an abundant platelet receptor of the integrin family that plays a primary role in platelet aggregation. It exists on the platelet surface predominantly in a resting or inactive conformation that is converted to an active binding competent conformation upon platelet activation. There is much interest in studying the difference between active and inactive GP IIb-IIIa, developing therapeutic agents targeted towards GP IIb-IIIa and developing diagnostic assays for antibodies that recognize epitopes on GP IIb-IIIa. We present here the development of a large-scale process for purifying active GP IIb-IIIa from human platelets. The procedure results in 25mg batch sizes of high purity and activity. Additionally, the effects of detergent concentration and impurities such as IgG on ELISA assays are examined.


Asunto(s)
Plaquetas/química , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/aislamiento & purificación , Western Blotting , Extractos Celulares , Cromatografía de Afinidad , Concanavalina A/metabolismo , Detergentes , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Humanos , Inmunoglobulina G/aislamiento & purificación , Oligopéptidos/metabolismo , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...